An H5N1-based matrix protein 2 ectodomain tetrameric peptide vaccine provides cross-protection against lethal infection with H7N9 influenza virus

An H5N1-based matrix protein 2 ectodomain tetrameric peptide vaccine provides cross-protection against lethal infection with H7N9 influenza virus

Emerging Microbes & Infections 4,
e22 (April 2015). doi:10.1038/emi.2015.22

Authors: Ho-Chuen Leung, Chris Chung-Sing Chan, Vincent Kwok-Man Poon, Han-Jun Zhao, Chung-Yan Cheung, Fai Ng, Jian-Dong Huang & Bo-Jian Zheng

Source: Emerging Microbes and Infections - April 8, 2015 Category: Infectious Diseases Authors: Ho-Chuen LeungChris Chung-Sing ChanVincent Kwok-Man PoonHan-Jun ZhaoChung-Yan CheungFai NgJian-Dong HuangBo-Jian Zheng Tags: influenza A virus H7N9 M2e peptide vaccine cross protection Source Type: research